These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20878267)

  • 1. Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage.
    Rizos T; Jenetzky E; Herweh C; Unterberg A; Hacke W; Veltkamp R
    Neurocrit Care; 2010 Dec; 13(3):321-5. PubMed ID: 20878267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage.
    Rizos T; Jenetzky E; Herweh C; Hug A; Hacke W; Steiner T; Veltkamp R
    Ann Neurol; 2010 Jun; 67(6):788-93. PubMed ID: 20517940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants.
    Rizos T; Herweh C; Jenetzky E; Lichy C; Ringleb PA; Hacke W; Veltkamp R
    Stroke; 2009 Nov; 40(11):3547-51. PubMed ID: 19696414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.
    Barillari G; Pasca S; Barillari A; De Angelis V
    Blood Transfus; 2012 Jan; 10(1):87-94. PubMed ID: 22044952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid bedside coagulometry prior to urgent neurosurgical procedures in anticoagulated patients.
    Beynon C; Jakobs M; Rizos T; Unterberg AW; Sakowitz OW
    Br J Neurosurg; 2014 Jan; 28(1):29-33. PubMed ID: 24313307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
    Edavettal M; Rogers A; Rogers F; Horst M; Leng W
    Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point of care coagulometry in prehospital emergency care: an observational study.
    Beynon C; Erk AG; Potzy A; Mohr S; Popp E
    Scand J Trauma Resusc Emerg Med; 2015 Aug; 23():58. PubMed ID: 26260487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
    Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
    Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
    Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
    Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal.
    Baggs JH; Patanwala AE; Williams EM; Erstad BL
    Ann Pharmacother; 2012 Jan; 46(1):51-6. PubMed ID: 22190253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-factor prothrombin complex concentrate dose response relationship with INR for warfarin reversal.
    Yohe AS; Livings SE
    Am J Emerg Med; 2019 Aug; 37(8):1534-1538. PubMed ID: 31130370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-management of oral anticoagulation therapy--methodological and clinical aspects.
    Christensen TD
    Dan Med Bull; 2011 May; 58(5):B4284. PubMed ID: 21535992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of point-of-care coagulometer measurements in patients with acute ischaemic stroke receiving intravenous fibrinolysis.
    Guisado-Alonso D; Fayos-Vidal F; Martí-Fàbregas J; Prats-Sánchez L; Marín-Bueno R; Martínez-Domeño A; Delgado-Mederos R; Camps-Renom P
    Neurologia (Engl Ed); 2020 Apr; 35(3):155-159. PubMed ID: 28958393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal.
    Bitonti MT; Rumbarger RL; Absher RK; Curran LM
    J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants?
    Mangram A; Oguntodu OF; Dzandu JK; Hollingworth AK; Hall S; Cung C; Rodriguez J; Yusupov I; Barletta JF
    J Crit Care; 2016 Jun; 33():252-6. PubMed ID: 27021851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values.
    Johnson SA; Vazquez SR; Fleming R; Lanspa MJ
    Am J Health Syst Pharm; 2017 Jan; 74(1):e24-e31. PubMed ID: 28007718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.